More high-risk patients with pulmonary embolism (PE) should be considered for surgery, according to a new scientific statement presented Monday, Jan. 23, at the…

Using coronary CT angiography (CCTA) to evaluate coronary artery disease (CAD) is associated with lower hospitalization and mortality rates…

Two recently developed risk scores can identify bleeding risks among high-risk percutaneous coronary intervention (PCI) patients, according to new findings published in the American Journal of Cardiology.[1] These scores…

Clopidogrel monotherapy after just one month of dual-antiplatelet therapy (DAPT) may help reduce the risk of major bleeding events when diabetic patients undergo percutaneous coronary intervention (PCI), according to a new study…

Intravascular lithotripsy (IVL) may offer substantial value to clinicians performing transcatheter mitral valve replacement (TMVR) on patients with severe stenosis and mitral regurgitation (MR), according to new findings published in…

Medtronic has announced that patient enrollment is officially underway for a new head-to-head global study comparing the company’s Endurant II/IIs stent graft system with Gore Medical’s Excluder AAA systems.

…

Stroke patients treated with mechanical thrombectomy (MT) face a significantly higher risk of 90-day mortality if they present with atrial fibrillation (AFib), according to a new meta-analysis published in …

AVS, a Michigan-based medical device company focused on interventional cardiology, has raised $20 million in Series B financing. The funding is expected to help AVS ramp up work on its Pulse Pulsatile-Intravascular Lithotripsy (P-IVL…

Black patients are 41% more likely than white patients to experience a prolonged length of stay after going to the hospital for acute ischemic stroke, according to a new study published in …

Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis…

Siemens Healthineers has announced Corindus, the vascular robotics company it acquired back in 2019, has been renamed Siemens Healthineers Endovascular Robotics. It is now part of the advanced therapies division within Siemens…

Medications designed to treat rheumatoid arthritis (RA) and Parkinson’s disease have been associated with key cardiovascular benefits, according to two recent studies.

The studies were unrelated and…

Fucoidan, a natural material derived from seaweed, may be able to boost cardiac surgery outcomes, according to a new analysis published in Bioactive Materials.[1] The research is still limited to small animal models thus far…

Embracing a plant-based diet can improve a person’s cardiovascular health, according to a new commentary published in the American Journal of Cardiology.[1] The article, titled “Are We What We Eat? The Moral Imperative of the…

Researchers have developed a new artificial intelligence (AI) model capable of predicting a patient’s 10-year risk of death from a heart attack or stroke—all…

CSL has announced that etranacogene dezaparvovec-drlb, the company’s new gene therapy for adult patients with hemophilia B, has been approved by the U.S. Food and Drug Administration (FDA). …

Bypass surgery is associated with fewer repeat procedures and amputations than endovascular treatment options such as angioplasty and stenting when treating patients with chronic limb-threatening ischemia (CLTI), according…

Paclitaxel drug-coated balloons (DCBs) are an effective treatment option for the treatment of femoropopliteal artery disease and femoropopliteal in-stent restenosis, according to two late-breaking clinical trials presented…